Rosuvastatin Enhances Alveolar Fluid Clearance in Lipopolysaccharide-Induced Acute Lung Injury by Activating the Expression of Sodium Channel and Na,K-ATPase via the PI3K/AKT/Nedd4-2 Pathway.
Hao-Ran XuQian YangShu-Yang XiangPu-Hong ZhangYang YeYan ChenKe-Wen XuXi-Ya RenHong-Xia MeiChen-Xi ShenHong-Yu MaFang-Gao SmithSheng-Wei JinQian WangPublished in: Journal of inflammation research (2021)
In summary, the findings of our study revealed the potential role of rosuvastatin in the management of ALI/ARDS.